Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 538,399 | 510,932 | 500,879 | 0 | 464,277 |
| Gross Profit | 538,399 | 510,932 | 500,879 | N/A | 464,277 |
| Operating Expenses | 27,832 | 101,586 | 139,449 | 0 | -68,221 |
| Operating Income | 510,567 | 409,346 | 361,430 | N/A | 532,498 |
| Interest Expense | 31,444 | 34,189 | 53,584 | 0 | 68,796 |
| Other Income | 145,131 | 226,819 | -198,750 | 0 | -23,675 |
| Pre-tax Income | 624,254 | 601,976 | 109,096 | 0 | 440,027 |
| Net Income Continuous | 624,254 | 601,976 | 109,096 | N/A | 440,027 |
| Minority Interests | 333,622 | 159,902 | 37,856 | N/A | 31,045 |
| Net Income | $290,632 | $442,074 | $71,240 | $N/A | $408,982 |
| EPS Basic Total Ops | 0.79 | 0.09 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 1.69 | 1.70 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.79 | 0.09 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 1.69 | 1.70 | N/A | N/A | N/A |
| EBITDA(a) | $518,892 | $416,941 | $369,641 | $N/A | $541,459 |